SA
Insider
Sherry Aulin
Chief Financial OfficerSherry Aulin (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $771K of XENE (18,709 sh across 2 lots, as filed), executed Dec 18 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$771K
shares × price, as filed
Last traded
Dec 18 2024
Filed Dec 19 2024
Median ADV $85.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $771K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
XENERecent filings
XENESALE
Xenon Pharmaceuticals Inc.
View filing →
$771K18,709 sh across 2 lots
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET